What if you could learn the secrets behind one of psychiatry's most significant breakthroughs in decades? In this episode of Power to the Patients, host Brandon Li sits down with Steve Brannan, Chief Medical Officer of Karuna Therapeutics, to explore the art of clinical trial excellence, the future of precision psychiatry, and the untold story behind developing the first new-mechanism schizophrenia drug in decades. Whether you're a researcher, clinician, or industry professional, this conversation

Ardra Shephard, a musician, author, fashion-show TV host, podcaster, and MS advocate, discusses her experiences living with MS, including how she uses her story to educate and encourage others living with MS. She is joined by Jiwon Oh, MD, Medical Director of the Barlo Multiple Sclerosis Program at St. Michael’s Hospital, Toronto, ON, who describes how advancements in the diagnosis and treatment of MS have improved outcomes for individuals living with this condition.

Lisa Volenec, a patient advocate and General Manager of KMTV, Omaha, NE, shares how incorporating lifestyle modifications—such as diet, exercise, and community engagement—has enhanced her Parkinson disease treatment. She is joined by double-board-certified neurology and lifestyle medicine physician and fellowship-trained movement disorder specialist Rachel Dolhun, MD, DipABLM, principal medical advisor at The Michael J. Fox Foundation, who offers expert insights on integrating these strategies into

Dagny Zhu, MD, joins Neda Nikpoor, MD, for a discussion on how a refractive surgeon can build an authentic, patient-facing brand on social media. They cover what actually drives consults—relatable education, selective personal storytelling, and platform fit—plus how to address anti-LASIK noise with evidence, handle trolls without grandstanding, and keep a sustainable cadence you’ll stick to.

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, spoke with R. Nolan Townsend, MBA, CEO of Lexeo Therapeutics, a company developing gene therapies for cardiovascular diseases as well as CNS disorders including Alzheimer’s disease.Lexeo recently announced a partnership to advance cardiac RNA therapeutics as well as $80 million in equity financing. Mr. Townsend has been CEO of Lexeo Therapeutics since 2020. He previously held

Pedja Filipović i Tanja Luković

Pushing biologics beyond 200 mg/mL isn’t just a formulation challenge - it’s a delivery, manufacturing, and regulatory challenge too. Aggregation, precipitation, and sky-high viscosity make scaling these therapies a gauntlet for drug developers.In this episode of Life Science Solutions, host Chris Adkins continues the conversation on hyper-concentrated biologics with Ryan Doxey, VP of Tech Ops & CMC at Kymanox, and Nick Letourneau, PhD, Associate Director of Product Development &

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, President, at Pharma & Biopharma Outsourcing Association (PBOA).Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gil, covering: How planned FDA budget cuts and the ongoing US government shutdown are impacting the industry. And the potential outlook if those issues remain unresolved... Why positive early-phase clinical trial

What is the difference between forward and reverse cardio-oncology? In our latest episode, Deputy Editor Dr. Carol Ann Remme (University of Amsterdam) interviews Dr. Rudolf de Boer (Erasmus Medical Center) about the new Review article by Meijers et al. Forward cardio-oncology focuses on cardiotoxicity and cardiac damage due to anti-cancer therapies in patients with prevalent cancer. In contrast, reverse cardio-oncology describes the phenomenon that cancer is more often discovered in patients with

This week, we welcome Jennifer Lentini, whose transplant journey began when she was just a teenager. On July 6, 1996, Jennifer received a life-saving heart transplant that gave her a second chance at life. But her story is far from over.Today, at age 42, Jennifer continues her fight. She joined us for this episode while on dialysis, awaiting a kidney transplant—and facing the reality that she may also need a second heart transplant. Jennifer’s story is one of

In this classic episode of Stuff to Blow Your Mind, Robert and Joe explore a host of scary, train-related topics, from the Victorian “railway madness” panic to ghost trains and more. (originally published 10/1/2024)See omnystudio.com/listener for privacy information.

This episode includes candid conversations about sex and relationships for informational purposes. Listener discretion advised.Should condoms be provided to students in welcome packets when they first arrive at college? Dr. Kami Kosenko joined us to discuss the importance of healthy communication and education surrounding the topic of sex. This episode dives into the various ways sex is taught to us and the components of sex that often get left out. From the topic of abstinence to the harmful

Grief, genetics, and accessible testing. In this episode, Matt Goldstein shares his personal journey through grief after the loss of his daughter, Javi, who was diagnosed with Tay-Sachs disease. He discusses the impact of this experience on his career, leading him to focus on preventive genetics and the mission of JScreen, an organization dedicated to providing genetic testing and support. We explore the importance of preconception carrier screening, the advancements in genetic technology, and the

What happens when the part of you that defines your identity begins to fail? Dana Swanson was a rising creative force—an award-winning writer-producer at Adult Swim, a voice actor, a musical performer, and a self-proclaimed comedy nerd on the brink of big things. But in 2012, her world unraveled when she began to lose control of her speech. What started as a stuttered sentence became a devastating diagnosis: a rare brain tumor—neuronal neoplasm—lodged in a precarious part of her

In this episode of Frame by Frame: Rethink Imaging, host Chris St. John sits down with Dr. Summer Kaplan, Associate Professor of Clinical Radiology at the University of Pennsylvania School of Medicine and pediatric radiologist at the Children’s Hospital of Philadelphia.Together, they explore the six pillars of healthcare quality, safety, timeliness, efficiency, effectiveness, equity, and patient-centeredness and how these principles shape modern radiology practice. From balancing efficiency with

Arne Jaksch is an expert in toxicology and managing director of his own company Jaksch Life Science Consulting. He supports medical technology, pharmaceutical and chemical companies in the biological and toxicological evaluation of their products. In our discussion we dive deep on how a toxicological risk assessment is performed and what difficulties companies usually face when doing these. This episode was sponsored by Jaksch LifeScience Consulting GmbH - JAKSCH LIFESCIENCE CONSULTING...

Send us a text What if the secret engine driving modern drug discovery wasn’t in Boston or Basel, but in Shanghai? In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead dives deep into the rise of WuXi AppTec, a company that redefined how the world develops medicine. We explore its fascinating journey, from a humble chemistry startup founded by Dr. Ge Li to a global R&D and manufacturing giant that helps nearly every top pharma and biotech company bring therapies to l...

در این اپیزود یه همراه دوست و همکار عزیزم رضا امیر-میزبان پادکست مهرانگیز- به یکی از بنیادی‌ترین پرسش‌های انسان معاصر می‌پردازیم: آیا فرزندآوری امری اخلاقی است؟ در گذشته، داشتن فرزند امری طبیعی و حتی وظیفه‌ای دینی و اجتماعی شمرده می‌شد؛ اما امروز، با افزایش آگاهی از مسائل اقتصادی، زیست‌محیطی، روانی و فلسفی، بسیاری از ما از خود می‌پرسیم: آیا آوردن انسانی دیگر به جهانی پر از بحران، فقر و نابرابری تصمیم درستی است؟ در این گفت‌وگو، نگاهی می‌اندازیم به دیدگاه‌های فلسفی، اخلاقی، مذهبی و زیست‌شناختی ...

🧠 فرگشت مغز انسان در جلسه ششم با حضور دکتر تقی کیمیایی‌اسدی، پزشک و عصب‌شناس برجسته، درباره‌ی مسیر فرگشتی مغز انسان، ساختارهای اصلی آن، و نقش محیط، در رشد مغز انسان صحبت می‌کنیم. داستان مغز انسان، داستان میلیون‌ها سال سازگاری و تغییر است — از مغزهای ساده‌ی ماهیان اولیه تا ساختار پیچیده‌ای که امروز تفکر، یادگیری و خلاقیت ما را ممکن می‌سازد. در طول این مسیر طولانی، مغز نیاکان ما به‌تدریج بزرگ‌تر و کارآمدتر شد؛ بخش‌هایی برای کنترل حرکت، احساسات، زبان و برنامه‌ریزی آینده شکل گرفتند. از مغز

BLTB debuts with a true story from deep within the Ruby Teys lore. Set in the eye of a Sydney City sh*tstom, navigating twenty-year-old chaos.It’s 2011: Galaxy Tights, Jeffrey Campbells, a smokey eye and doughnut buns. Ruby’s learning to fend for herself — one hungover at a time.True stories from the year everything was completely off and somehow perfectly brilliant.Transciption and extras assets avaliable here: https://substack.com/@theblondeleadingtheblind?Instagram: